Regulation of nucleotide metabolism by mutant p53 contributes to its gain-of-function activities

Kollareddy, Madhusudhan, Dimitrova, Elizabeth, Vallabhaneni, Krishna C., Chan, Adriano, Le, Thuc, Chauhan, Krishna M., Carrero, Zunamys I., Ramakrishnan, Gopalakrishnan +8 more·2015·Nature Communications
DOI 10.1038/ncomms8389

Cited by (127)

Items 101–127 of 127

  1. TP53 Mutant Acute Myeloid Leukemia: The Immune and Metabolic Perspective
    Federico Zingarelli, Letizia Zannoni, Antonio Curti · 2022 · Hemato
  2. GABPB1 plays a cancer-promoting role in non-small cell lung cancer
    Tuo Wang, Cong Cao, Yu Fan, Jialing Xu, Tao Hua, Jie Ding, Zejie Liu, Beili Wang, Juanwen Lian · 2024 · Discover Oncology
  3. Transcriptomic profiling identifies a nucleotide metabolism-related signature with prognostic power in gliomas
    Aiqin Chen, Qi-Xuan Jiang, Yong-Jian Zhu, Qiangwei Wang · 2024 · Translational Oncology
  4. Protective role of p53 in doxorubicin-induced cardiomyopathy as a mitochondrial disease
    Masahiro Nishi, Pingyuan Wang, Paul M. Hwang · 2020 · Molecular & Cellular Oncology
  5. Frame-shift mediated reduction of gain-of-function p53 R273H and deletion of the R273H C-terminus in breast cancer cells result in replication-stress sensitivity
    Viola Ellison, George K. Annor, Clara Freedman, Gu Xiao, Devon Lundine, Elzbieta Freulich, Carol L. Prives, Jill Bargonetti · 2021 · Oncotarget
  6. Assessment of Intracellular GTP Levels Using Genetically Encoded Fluorescent Sensors
    Anna Bianchi, Mikhail A. Nikiforov · 2022 · Methods in molecular biology
  7. Pyrimidine metabolism reshapes immune microenvironment and implies poor prognosis in glioma
    Ruoyu Huang, Jingchen Yang, Xuejing Li, Huiyuan Chen, Xing Liu · 2024 · Clinical & Translational Oncology
  8. p53 and cancer metabolism
    Xian-Hong ZHANG, Le LI · 2022 · Scientia Sinica Vitae
  9. Mutant TP53 promotes invasion of lung cancer cells by regulating desmoglein 3
    Yu Ying Feng, Rulin Qian, Cui Dong, Jiaqiang Luan, Mingxing Xu, Ling Wang, Ruijie Li, Xiao Wu, Chaoying Chang · 2024 · Journal of Cancer Research and Clinical Oncology
  10. A prognostic 15-gene model based on differentially expressed genes among metabolic subtypes in diffuse large B-cell lymphoma
    Jun Hou, Peng Guo, Yujiao Lu, Xiaokang Jin, Ke Liang, Na Zhao, Shunxu Xue, Chengmin Zhou, Bing Wang, Zhu Xin et al. · 2023 · Pathology & Oncology Research
  11. Metabolic dysregulation in cancer progression
    Saniya Arfin, Kirti Agrawal, Ashok Kumar, Arun J. Kumar, Brijesh Rathi, Dhruv Kumar · 2022 · Elsevier eBooks
  12. Clinical translation of metabolomics markers in endometrial carcinoma
    Nur Fatin Nabilah Mohd Sahardi, Manishaa Priya, Suzana Makpol, Mohamad Nasir Shafiee · 2025 · Journal of obstetrics and gynaecology research
  13. ENY2 transcription and export complex 2 subunit deficiency induces nucleolar stress to inhibit tumor progression through NPM1/MDM2/p53-dependent and -independent responses
    Shiqi Zuo, He S, Zhiqin Zhu, Yanjie Hou, Ziqing Wu, Yao Tang, Yujiao Zou · 2026 · Cellular Oncology
  14. Dynamic control of nucleotide metabolism in physiology and disease
    Dohun Kim, Gerta Hoxhaj · 2026 · Nature Cell Biology
  15. Development of Novel Therapeutic Response Biomarkers
    Nils Elander, Karen Aughton, William Greenhalf · 2018 · Springer eBooks
  16. The tAnGo fell short of inspiring the audience
    Dimitriοs Mavroudis · 2017 · The Lancet Oncology
  17. Development of Novel Therapeutic Response Biomarkers
    Nils Elander, Karen Aughton, William Greenhalf · 2017 · Springer eBooks
  18. Gain-of-function and dominant-negative effects of distinct p53 mutations in lung tumours
    Frances K. Turrell · 2018 · Apollo (University of Cambridge)
  19. Defining Roles of Metabolic Reprogramming in Pancreatic Tumorigenesis and Tumor Maintenance
    Barbara Scott Nelson · 2020 · Deep Blue (University of Michigan)
  20. Mutant p53 Associates with Human Equilibrative Nucleoside 1 Upregulation and Better Response to Adjuvant Gemcitabine in Intrahepatic Cholangiocarcinoma Patients
    Marzia Deserti, Valeria Relli, Andrea Palloni, Francesco Vasuri, Deborah Malvi, Alessio Degiovanni, Simone Rimedio, Chiara Delbaldo, Chiara Deiana, Giovanni Brandi et al. · 2025 · International Journal of Molecular Sciences
  21. TP53-dependent antitumor effects of DHODH Inhibition in nasopharyngeal carcinoma
    Xingchen Dong, Yaoting Zhang, Zhicun Zhang, Ting Liu, Dongsheng Gu · 2025 · Discover Oncology
  22. Deoxycytidine kinase inhibition: Rewiring tumor nucleotide metabolism for therapeutic gain
    Peter M. Clark, Curtis B. Thompson, Kenneth A. Schultz · 2026 · Nucleosides Nucleotides & Nucleic Acids
  23. Apprentissage de réseaux causaux avec variables latentes et applications à des contextes génomiques et cliniques
    Louis Verny · 2017
  24. Network analysis of genomic and clinical data
    Nadir Sella · 2019
  25. Revisiting tumor immunogenicity through the lens of mutant p53: Implications for cancer immunotherapy
    Sourio Chakraborty, Sumon Mukherjee, Subhajit Ghosh, Udit Basak, Sumoyee Mukherjee, Arghya Adhikary, Gaurisankar Sa, Tanya Das · 2026 · APOPTOSIS
  26. Ribonucleotide Reductase Inhibition Triggers Ferroptosis in Genetically Defined Subsets of Non–Small Cell Lung Cancer
    Utsav Sen, Dalia S. Natour, Subhamoy Chakraborty, Élisa Gobbini, Chih-wei Fan, Calvin Koelbel, Andrew Elliott, Ari M. Vanderwalde, Hossein Borghaei, Balázs Halmos et al. · 2026 · Cancer Research Communications
  27. In Cellulo Observation of De Novo -Synthesized Nucleotide by Spectral Tracing of Glutamine-Derived Nitrogen Metabolism (QN-STIM) in Cancer Cells
    Jiro Karlo, Surya Pratap Singh · 2026 · Analytical Chemistry